the juxtaglomerular apparatus of the kidney. Successful treatment necessitates restoration of normal aortorenal blood flow. This study undertook computational modeling to define the effectiveness of thoracoabdominal bypass (TAB) and patch aortoplasty (PA) in achieving normal postoperative renal artery flow using retrospective data from an abdominal aortic coarctation patient treated with TAB.
Methods: Patient-specific anatomic models were constructed from preoperative computed tomography angiograms (Fig 1) . Fluid-structure interaction analyses of hemodynamics were performed to quantify changes in renal flow and pressure waveforms after TAB and PA.
Results: Preoperative results revealed diastole-dominated renal artery flow with considerable high-frequency disturbances (Fig 2) . Postoperative increases in systolic flow and decreases in high-frequency disturbances accompanied both TAB and PA. However, whereas PA resulted in nearly normal renal flow waveforms, a degree of high-frequency renal flow disturbances persisted after TAB. Furthermore, postoperative decreases in collateral flow distributions accompanied both TAB and PA. In addition, the postoperative TAB right and left kidney volumes increased by 32% and 56%, respectively, paralleling the increased volumetric renal artery flows predicted by the TAB fluid-structure interaction analysis.
Conclusions: Both TAB and PA dramatically improved renal artery flow and pressure waveforms. Importantly, PA eliminated high-frequency renal flow disturbances, resulting in nearly normal aortorenal blood flow. Therefore, this study documented a superior hemodynamic performance of PA over TAB treatment for suprarenal abdominal aortic coarctations. The study also confirms the relevance of patient-specific computational modeling in planning of interventions for complex vascular diseases. Objective: The objective of this study was to assess results of physical therapy management (PTM) and surgical treatment (SRx) in a prospective observational cohort of patients with neurogenic thoracic outlet syndrome (NTOS) using standardized patient-reported outcomes measures (PROMs).
Methods: Of 183 new patient referrals between July 1 and December 31, 2015, there were 150 patients (82%) who met established clinical diagnostic criteria for NTOS. All patients underwent PTM, and those with unsatisfactory symptom improvement underwent SRx (supraclavicular decompression or pectoralis minor tenotomy). Pretreatment factors and seven PROMs were compared between PTM and SRx patients, with follow-up results assessed by changes in PROMs and patient-rated outcomes.
Results: Forty patients (27%) obtained satisfactory improvement with PTM alone, and 20 (13%) declined further treatment or follow-up, whereas 90 (60%) underwent SRx after unsuccessful PTM. There were no differences between the PTM and SRx groups with regard to age, sex, duration of symptoms, previous injury, pain-or depression-related PROM scores, pain catastrophizing scores, or frequency of positive scalene muscle blocks. The mean (6 standard error of the mean) degree of local tenderness to palpation (1.7 6 0.1 vs 2.0 6 0.1; P ¼ .031) and number of positive clinical diagnostic criteria (9.0 6 0.3 vs 10.1 6 0.1; P ¼ .001) were slightly lower in PTM vs SRx patients, whereas 12-Item Short Form Health Survey physical scores (35.6 6 1.5 vs 32.0 6 0.8; P ¼ .019) were slightly lower in the SRx group and shortened Disabilities of the Arm, Shoulder, and Hand (QuickDASH) questionnaire scores were equivalent (52.9 6 3.4 vs 60.3 6 2.1; P ¼ .058). During median follow-up of 15.1 months, the mean decline in QuickDASH score for PTM patients was À15.6 6 3.0 (À29.5% 6 5.7%) compared with À29.8 6 2.4 (À47.9% 6 3.6%) for SRx patients (P < .001; Fig 1) . Patient-rated outcomes for SRx were excellent in 27%, good in 37%, fair in 25%, and poor in 11%, with a strong association between the extent of improvement in QuickDASH score and patient-rated outcome (P < .001; Fig 2) .
Conclusions: SRx for NTOS was effective when PTM was insufficient, even with substantial pretreatment disability. Satisfactory outcomes were obtained after SRx in approximately 90% of patients, with Background: The appropriate surgical treatment of effort thrombosis in young patients with venous thoracic outlet syndrome (TOS) is controversial. The major approaches include supraclavicular, infraclavicular, paraclavicular, and transaxillary first rib resection. We present the successful paraclavicular surgical management for the relatively rare observation of recurrent venous TOS with effort thrombosis 5 years after transaxillary rib resection.
Case presentation: This is a 23-year-old woman and professional athlete who had a previous left first rib transaxillary resection in 2012 at an outside institution for venous TOS of the subclavian vein and developed recurrence of massive left upper extremity swelling and pain. She initially underwent balloon angioplasty, with suggestion of hypercoagulability as the cause for recurrence. Subsequent imaging 5 years later at our institution showed subclavian vein thrombosis, and this was confirmed with dynamic venography. A paraclavicular thoracic outlet decompression with complete first rib resection to the sternum and cervical spine was performed, followed by thrombolysis of the subclavian vein and balloon angioplasty. Success was confirmed with a patent subclavian vein on intraoperative dynamic venography and complete elimination of symptoms postoperatively.
Conclusions: This case demonstrates that recurrence of symptoms after transaxillary first rib resection is potentially due to residual first rib compression at the costoclavicular junction. Additional surgical decompression with complete first rib resection may be necessary to prevent recurrent venous compression and thrombosis. Objective: Thoracic endovascular aortic repair (TEVAR) has expanded access to thoracic aortic aneurysm (TAA) repair, particularly for elderly and frail patients. However, there are limited data on this higher risk population to inform appropriate selection of patients. Our objective was to develop and to validate a frailty-based, procedure-specific risk score for patients undergoing TEVAR for elective TAA.
Methods: Patients undergoing nonemergent TEVAR for TAA during 2005 to 2016 in the National Surgical Quality Improvement Program database were randomized to derivation or validation cohorts. The primary outcome was 30-day major adverse events (MAEs), including mortality and major complications. Using the derivation cohort, variables associated with MAEs were identified by univariable analyses. Those with P < .05 were included in multivariable logistic regression analysis. Independent procedure-specific and frailty-related risk factors for MAEs were used to develop a pragmatic score to assess risk for TEVAR.
Results: Overall, 1920 patients were included (960 derivation, 960 validation); 16% of derivation patients had MAEs (15% major complications, 4% mortality), which were primarily associated with markers of frailty and TEVAR extent (Table) . Independent risk factors for MAEs were chronic pulmonary disease (odds ratio [OR], 1.8; 95% confidence interval [CI], 1.3-2.6), functional dependence (OR, 2.9; 95% CI, 1.7-5.2), and zone 2 involvement (OR, 1.7; 95% CI, 1.2-2.4). Assigning each variable 1 point, a total risk score of 0 to 3 was generated with progressive rates of MAEs (Fig) , enabling classification as low risk (0 points; 38% of patients; mortality <5%; MAEs <15%), intermediate risk (1 point; 45% of patients; mortality <10%; MAEs <20%), or high risk ($2 points; 17% of patients; mortality >10%; MAEs >20%). Validation patients had similar characteristics and calculated risk profile.
Conclusions: Markers of frailty and procedure extent strongly predict MAEs after TEVAR for TAA and can improve selection of patients by enabling patient-and procedure-specific risk stratification. Whereas TEVAR is safe in low-risk patients, intermediate-risk patients warrant careful discussion of the risks and benefits of aortic intervention; under certain circumstances, high-risk patients may not benefit. Further study is required to define the association between frailty and long-term outcomes. 
